Table 1 Participant characteristics grouped by patient-reported dose satisfaction (N = participant-observations), with significant p-values from unadjusted generalized estimating equations

Age^b

45.30 (8.91)

45.86 (8.69)

43.37 (9.43)

Gender^b

 Female

155 (28%)

110 (26%)

45 (37%)

 Male

390 (72%)

313 (74%)

77 (63%)

First Nations, Métis, or Inuit^b

 No

385 (71%)

311 (74%)

74 (61%)

 Yes*

160 (29%)

112 (26%)

48 (39%)

Education^b

 Less than high school

230 (42%)

172 (41%)

58 (48%)

 High School

138 (25%)

103 (24%)

35 (29%)

 At least some post-secondary

177 (32%)

148 (35%)

29 (24%)

EQ5D-CAN Score^c

0.79, (0.21)

0.80, (0.21)

0.76, (0.21)

OTI Total Health Score (without gynecological subscale)** ^c

46.88 (25.98)

44.51 (26.36)

54.96 (22.97)

Ever Attempted Suicide^b

 No

398 (74%)

327 (78%)

71 (59%)

 Yes*

142 (26%)

92 (22%)

50 (41%)

Age First Injected Any Drug* ^b

23.17 (8.06)

23.68 (8.18)

21.40 (7.38)

Days with heroin use in past month* ^c

4.35 (8.25)

3.76 (7.62)

6.38 (9.90)

Number of days (out of past 30) patient smoked crack cocaine ^c

5.14 (10.28)

5.00 (10.29)

5.63 (10.29)

FTND ^c

 Non-Smoker

66 (12%)

63 (15%)

3 (2.5%)

 Smoker**

478 (88%)

360 (85%)

118 (98%)

Whether patients were troubled to any extent by any drug problems³

 No

257 (47%)

218 (52%)

39 (32%)

 Yes**

288 (53%)

205 (48%)

83 (68%)

MAP Psychological Health Score** ^c

8.49 (7.37)

7.68 (6.95)

11.29 (8.12)

Average Daily Dose Prescribed^c

562.59 (261.58)

555.93 (257.78)

585.91 (274.28)

Patient's rating of doctor involving them in decisions as much as they wanted^c

 Less Than Excellent

275 (52%)

199 (48%)

76 (65%)

 Excellent**

254 (48%)

213 (52%)

41 (35%)

Drug Liking VAS*** ^c

74.22 (24.17)

78.08 (21.08)

61.02 (29.05)